免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料，僅供一般參考，不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Aveir DR Real-World Evidence Post-Approval Study

NCT：NCT05935007 · RECRUITING

NCT IDNCT05935007

狀態RECRUITING

開始日期2023-10-31

完成時間2030-12-31

SponsorAbbott Medical Devices (INDUSTRY)

First posted2023-07-07

Last updated2026-05-20

簡要摘要

The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑